Talk-to-Jo" Intelligent Digital Health Companion, Neurocognitive Disorders and Dyads

Recruiting Observational Study
Caregiver Neurocognitive Disorders
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
65 and older
Sex
Any
Study type
Observational
Participants needed
40 (estimated)
Sponsor
Olivier Beauchet · Government
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
By 2050, one in six people in the world will be over 65, leading to an increase in the number of people with neurocognitive disorders (NCD), such as Alzheimer's disease. The number of cases will rise from 57 million to 153 million by 2050. This presents challenges for healthcare systems, as NCDs affect not only mental health but also the physical health, psychological well-being, and social relati…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
1. Person living with an neurocognitive disorder (NCD): 1. Inclusion criteria: * Be 65 years old or older. * Have an NCD, whether minor or major, in a mild to moderate stage, diagnosed within the past year. * Be receiving care for an NCD at the outpatient clinic of the Montrea…
Contacts

Olivier Beauchet, MD

5143403540

olivier.beauchet@umontreal.ca

CONTACT